CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Company Snapshot
Zhongyuan Union Cell & Gene Engineering Corp Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhongyuan Union Cell & Gene Engineering Corp Ltd with three other companies in this sector in China: Tianjin Ringpu Bio-Technology Co Ltd (2017 sales of 1.05 billion Chinese Renmimbi [US$164.47 million] ), Zhenxing Biopharmaceutical & Chemical Co Ltd (685.38 million Chinese Renmimbi [US$107.63 million] of which 99% was Pharmaceutical Sales), and Walvax Biotechnology Company Limited (668.26 million Chinese Renmimbi [US$104.94 million] ).

Sales Analysis. During the year ended December of 2017, sales at Zhongyuan Union Cell & Gene Engineering Corp Ltd were 868.97 million Chinese Renmimbi (US$136.46 million). This is an increase of 4.0% versus 2016, when the company's sales were 835.64 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Zhongyuan Union Cell & Gene Engineering Corp Ltd (and since 2012, sales have increased a total of 206%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhongyuan Union Cell & Gene Engineering Corp Ltd
  Stock Performance Chart for Zhongyuan Union Cell & Gene Engineering Corp Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 21.30
(Figures in Chinese Renmimbi)
1 Week -6.6%   13 Weeks 1.3%  
4 Weeks 6.0%   52 Weeks 2.4%  
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Key Data:
  Ticker: 600645 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 868,972,584
(Year Ending Jan 2018).
Employees: 1,981
  Currency: Chinese Renmimbi Market Cap: 8,183,871,388
  Fiscal Yr Ends: December Shares Outstanding: 384,219,314
  Share Type: A Gu Closely Held Shares: 120,716,902
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.